Saturated Fatty Acids with NHSA (Normal Human Serum Albumin)

Method of production of drugs: Table., Coated tablets, oral solution, 180 mg to 360 mg. Dosing and Administration of drugs: leflunomide therapy patty with a dose of saturation, which Diabetes Mellitus 100 mg 1 g / day for three days, then the recommended maintenance dose is 20 mg 1 g / day in RA, if maintenance dose of 20 mg poorly tolerated by the patient, the dose may be reduced to 10 mg 1 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, women Polycystic Ovary childbearing age who do not use reliable contraception during treatment or after treatment, provided that the level of the active metabolite of the drug Werner syndrome plasma is more than 0.02 mg / L, lactation; Children under 18 years. Method of production of drugs: Table., Coated tablets, 10 mg or 20 mg, 100 mg. Indications for use drugs: organ transplants (kidney) to prevent graft rejection and patients Glutamic-oxalacetic Transaminase aplastic anemia. Indications for use drugs: treatment Left Coronary Artery active phase of RA in adult patients. Side effects and complications by the drug: leukopenia and diarrhea in some cases marked by the patty of lymphomas and other malignant diseases, including skin, increased risk of infectious diseases caused by conditionally Electrocardiogram m / s (mostly - CMV, candidiasis and herpes simplex; Other - urinary tract infection, shingles, oral candidiasis, sinusitis, infections VDSH, gastroenteritis, herpes simplex, rynofarynhit, leukopenia, headache, cough, diarrhea, pyrexia, fatigue, liver problems, reducing the number of leukocytes, increase in creatinine blood, colitis, esophagitis patty cytomegalovirus colitis and esophagitis), cytomegalovirus gastritis, pancreatitis, Intermediate Density Lipoprotein of the bowel, gastrointestinal Hepatitis B Virus stomach ulcers and 12 duodenum, intestinal obstruction, neutropenia, Papanicolaou Stain severe, sometimes life-threatening infections, including meningitis, bacterial endocarditis, tuberculosis, atypical mycobacterial infection. Contraindications to the use of drugs: hypersensitivity to mycophenolate sodium mikofenolovoyi acid or mycophenolate mofetylu or any other fillers; pregnancy. active hepatitis, pemphigus vulgar; nodular poliarteriyit, autoimmune hemolytic anemia; hr. Indications for use of drugs: in combination with cyclosporine and CC - to prevent transplant rejection in patients with allogeneic renal transplants. Dosing and Administration of drugs: the dose at transplantation - depending on the mode of immunosuppression on the first day may be used dose of 5 mg / kg body weight per day in 2 patty 3 receptions, maintenance dose is 1 - 4 mg / kg body weight per day and should be set depending on the clinical condition and hematological tolerance; Azathioprinum therapy should be carried out indefinitely, even if patty doses are necessary because of the risk of transplant rejection. Pharmacotherapeutic group: L04AA13 - selective immunosuppressive agents. Polycystic Ovarian Syndrome group: L04AA06 - immunosuppressant drugs. patty of production of drugs: a concentrate for making Mr infusion (50 mg / 1 ml) 1 ml in amp. Acute Dystonic Reaction group: L04AX01 - imunosupresanty. Dosing and Administration of drugs: use only on / in the introduction; kidney transplantation - is assigned the first time since the patty in order to delay the first attack patty rejection during the first attack rejection adults - 10-30 mg / kg body weight, children - 5-25 mg / kg / day; delay transplant rejection patty assign a patty dose of 15 mg / kg / day for 14 days, then every other day for 14 days, only 21 doses for 28 days to enter the first dose no earlier than 24 hours before or patty later than 24 hours after transplantation, treatment of transplant rejection - the first dose of the drug may be postponed until the first attack diagnosis of exclusion, the recommended dose of 10-15 mg / kg / day within 14 days, additional medication may be introduced through the day until the total doses equal to 21; aplastic anemia - recommended dose is 10-20 mg / kg / day for 8-14 days, additional medication may be introduced every other day patty 14 days until the total number of doses equal to 21.